Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 2
1997 6
1998 10
1999 13
2000 15
2001 28
2002 40
2003 43
2004 46
2005 53
2006 49
2007 45
2008 41
2009 38
2010 44
2011 25
2012 18
2013 29
2014 27
2015 17
2016 15
2017 20
2018 21
2019 10
2020 8
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

612 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial.
Mahatme MS, Dakhale GN, Tadke K, Hiware SK, Dudhgaonkar SD, Wankhede S. Mahatme MS, et al. Indian J Pharmacol. 2016 Nov-Dec;48(6):649-653. doi: 10.4103/0253-7613.194854. Indian J Pharmacol. 2016. PMID: 28066101 Free PMC article. Clinical Trial.

The mean change of TNSS, i.e., 9.46 was significant (P < 0.05) in montelukast-fexofenadine group. The cost-effectiveness ratio was less in montelukast-levocetirizine group than in montelukast-fexofenadine group. CONCLUSION: The decrease in TNSS was more in

The mean change of TNSS, i.e., 9.46 was significant (P < 0.05) in montelukast-fexofenadine group. The cost-effectiveness ratio was

A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis.
Kim MK, Lee SY, Park HS, Yoon HJ, Kim SH, Cho YJ, Yoo KH, Lee SK, Kim HK, Park JW, Park HW, Chung JH, Choi BW, Lee BJ, Chang YS, Jo EJ, Lee SY, Cho YS, Jee YK, Lee JM, Jung J, Park CS. Kim MK, et al. Clin Ther. 2018 Jul;40(7):1096-1107.e1. doi: 10.1016/j.clinthera.2018.04.021. Epub 2018 Jun 24. Clin Ther. 2018. PMID: 29945738 Free article. Clinical Trial.
After a 1-week placebo run-in period, the subjects were randomized to receive montelukast (10 mg/day, n = 112) or montelukast (10 mg/day)/levocetirizine (5 mg/day) (n = 116) treatment for 4 weeks. ...For all other allergic rhinitis efficacy end points, the montel
After a 1-week placebo run-in period, the subjects were randomized to receive montelukast (10 mg/day, n = 112) or montelukast
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
Williams KM, Cheng GS, Pusic I, Jagasia M, Burns L, Ho VT, Pidala J, Palmer J, Johnston L, Mayer S, Chien JW, Jacobsohn DA, Pavletic SZ, Martin PJ, Storer BE, Inamoto Y, Chai X, Flowers MED, Lee SJ. Williams KM, et al. Biol Blood Marrow Transplant. 2016 Apr;22(4):710-716. doi: 10.1016/j.bbmt.2015.10.009. Epub 2015 Oct 22. Biol Blood Marrow Transplant. 2016. PMID: 26475726 Free PMC article. Clinical Trial.
We hypothesized that inhaled fluticasone, azithromycin, and montelukast (FAM) with a brief steroid pulse could avert progression of new-onset BOS. ...
We hypothesized that inhaled fluticasone, azithromycin, and montelukast (FAM) with a brief steroid pulse could avert progression of n …
Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial.
Sarkar TK, Sil A, Pal S, Ghosh C, Das NK. Sarkar TK, et al. Indian J Dermatol Venereol Leprol. 2017 Sep-Oct;83(5):561-568. doi: 10.4103/ijdvl.IJDVL_551_16. Indian J Dermatol Venereol Leprol. 2017. PMID: 28656910 Free article. Clinical Trial.
Quality of life was significantly improved in levocetirizine 5 mg + montelukast 10 mg group (P = 0.031). LIMITATIONS: The limitation of the study was that the follow-up period was 4 weeks. CONCLUSION: EAACI/GA[2]LEN/EDF/WAO guidelines need to be more flexible in allowing u …
Quality of life was significantly improved in levocetirizine 5 mg + montelukast 10 mg group (P = 0.031). LIMITATIONS: The limitation …
Exercise training as an adjunctive therapy to montelukast in children with mild asthma: A randomized controlled trial.
Zhang YF, Yang LD. Zhang YF, et al. Medicine (Baltimore). 2019 Jan;98(2):e14046. doi: 10.1097/MD.0000000000014046. Medicine (Baltimore). 2019. PMID: 30633202 Free PMC article. Clinical Trial.
The subjects in the treatment group received ET plus montelukast, while the participants in the control group received montelukast alone. ...RESULTS: After 6-week treatment and 2-week follow-up, although ET plus montelukast did not show better effectiveness i …
The subjects in the treatment group received ET plus montelukast, while the participants in the control group received montelukast
Early control treatment with montelukast in preschool children with asthma: A randomized controlled trial.
Nagao M, Ikeda M, Fukuda N, Habukawa C, Kitamura T, Katsunuma T, Fujisawa T; LePAT (Leukotriene and Pediatric Asthma Translational Research Network) investigators. Nagao M, et al. Allergol Int. 2018 Jan;67(1):72-78. doi: 10.1016/j.alit.2017.04.008. Epub 2017 May 16. Allergol Int. 2018. PMID: 28526210 Free article. Clinical Trial.
RESULTS: From September 2009 to November 2012, 93 patients (47 in the montelukast group and 46 in the no-controller group) were enrolled into the study. ...CONCLUSIONS: Montelukast is an effective control treatment for preschool children who had asthma symptoms more …
RESULTS: From September 2009 to November 2012, 93 patients (47 in the montelukast group and 46 in the no-controller group) were enrol …
Montelukast.
Markham A, Faulds D. Markham A, et al. Drugs. 1998 Aug;56(2):251-6; discussion 257. doi: 10.2165/00003495-199856020-00010. Drugs. 1998. PMID: 9711449 Review.
Montelukast is a selective antagonist of the leukotriene D4 (LTD4) receptor. ...Montelukast (5 mg/day) has also demonstrated efficacy in childhood asthma. ...
Montelukast is a selective antagonist of the leukotriene D4 (LTD4) receptor. ...Montelukast (5 mg/day) has also demonstrated e
Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma.
American Lung Association Asthma Clinical Research Centers. American Lung Association Asthma Clinical Research Centers. Am J Respir Crit Care Med. 2007 Feb 1;175(3):235-42. doi: 10.1164/rccm.200603-416OC. Epub 2006 Sep 22. Am J Respir Crit Care Med. 2007. PMID: 16998094 Clinical Trial.
Both montelukast and theophylline caused small improvements in prebronchodilator FEV(1) of borderline significance. ...For patients not using inhaled corticosteroids, low-dose theophylline improved asthma symptom control more than montelukast or placebo, and provide …
Both montelukast and theophylline caused small improvements in prebronchodilator FEV(1) of borderline significance. ...For patients n …
Evaluation of the effects of montelukast, mometasone furoate, and combined therapyon adenoid size: a randomized, prospective, clinical trial with objective data.
Tuhanıoğlu B, Erkan SO. Tuhanıoğlu B, et al. Turk J Med Sci. 2017 Dec 19;47(6):1736-1743. doi: 10.3906/sag-1701-179. Turk J Med Sci. 2017. PMID: 29306232 Free article. Clinical Trial.
Group 1 received 100 mug of mometasone furoate per day, group 2 received 4/5 mg (for age) montelukast per day, and group 3 received mometasone furoate + montelukast. ...There were statistically significant differences between pre- and posttreatment values in every s …
Group 1 received 100 mug of mometasone furoate per day, group 2 received 4/5 mg (for age) montelukast per day, and group 3 received m …
Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF. Meltzer EO, et al. J Allergy Clin Immunol. 2000 May;105(5):917-22. doi: 10.1067/mai.2000.106040. J Allergy Clin Immunol. 2000. PMID: 10808172 Clinical Trial.
OBJECTIVE: The purpose of this study was to determine the effect of concomitant use of montelukast and loratadine in the treatment of seasonal allergic rhinitis. ...Montelukast alone and loratadine alone caused modest improvements in rhinitis end points. ...
OBJECTIVE: The purpose of this study was to determine the effect of concomitant use of montelukast and loratadine in the treatment of …
612 results